News

Baroreflex activation therapy improves heart failure symptoms


 

AT ACC 15

References

Simultaneously with Dr. Abraham’s presentation at ACC 15, the study manuscript was published online (JACC: Heart Failure 2015 [doi: 10.1016/j.jchf.2015.02.006]).

Dr. Abraham is a consultant to CVRx (which funded the study), as well as Novartis, St. Jude Medical, CardioMEMS, and Abbott Vascular.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

PCI linked to higher rate of cardiovascular events than CABG
MDedge Internal Medicine
VIDEO: Did the PROMISE trial keep its promise?
MDedge Internal Medicine
Everolimus-eluting stents linked to higher MI risk than CABG
MDedge Internal Medicine
VIDEO: SAPIEN and CoreValve provide complementary TAVR options
MDedge Internal Medicine
Guideline recommends combination therapy for smoking cessation in cancer patients
MDedge Internal Medicine
Apple’s ResearchKit
MDedge Internal Medicine
Novel Watchman device approved as warfarin alternative in atrial fib
MDedge Internal Medicine
VIDEO: Long-term PARTNER 1 data tip scales toward TAVR
MDedge Internal Medicine
Midlife blood pressure patterns predict CVD, mortality risk
MDedge Internal Medicine
ACP: Avoid ECG, MPI cardiac screening in low-risk patients
MDedge Internal Medicine